The estimated Net Worth of Jeff R. Schroeder is at least $3.93 million dollars as of 8 May 2017. Jeff Schroeder owns over 40,000 units of Oxford Immunotec Global PLC stock worth over $2,795,963 and over the last 11 years Jeff sold OXFD stock worth over $1,131,200.
Sign up
Jeff Schroeder OXFD stock SEC Form 4 insiders trading
Jeff has made over 4 trades of the Oxford Immunotec Global PLC stock since 2017, according to the Form 4 filled with the SEC. Most recently Jeff sold 40,000 units of OXFD stock worth $565,600 on 8 May 2017.
The largest trade Jeff's ever made was exercising 65,175 units of Oxford Immunotec Global PLC stock on 4 April 2017 worth over $5,866. On average, Jeff trades about 18,133 units every 12 days since 2014. As of 8 May 2017 Jeff still owns at least 127,147 units of Oxford Immunotec Global PLC stock.
You can see the complete history of Jeff Schroeder stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Jeff Schroeder's mailing address?
Jeff's mailing address filed with the SEC is C/O OXFORD IMMUNOTEC GLOBAL PLC, 94C INNOVATION DRIVE, ABINGDON, OXFORDSHIRE, X0, OX14 4RZ.
Insiders trading at Oxford Immunotec Global PLC
Over the last 11 years, insiders at Oxford Immunotec Global PLC have traded over $13,598,906 worth of Oxford Immunotec Global PLC stock and bought 47,600 units worth $549,576 . The most active insiders traders include James R Tobin, Peter Wrighton Smith et Ronald Asbury Andrews. On average, Oxford Immunotec Global PLC executives and independent directors trade stock every 36 days with the average trade being worth of $536,006. The most recent stock trade was executed by Patrick J Balthrop on 20 May 2020, trading 4,000 units of OXFD stock currently worth $49,920.
What does Oxford Immunotec Global PLC's logo look like?
Complete history of Jeff Schroeder stock trades at Oxford Immunotec Global PLC
Oxford Immunotec Global PLC executives and stock owners
Oxford Immunotec Global PLC executives and other stock owners filed with the SEC include:
-
Peter Wrighton-Smith,
Chief Executive Officer, Director -
Matthew McLaughlin,
Chief Financial Officer -
Richard Sandberg,
Independent Director -
Patrick Balthrop,
Independent Chairman of the Board -
Herman Rosenman,
Independent Director -
James Tobin,
Independent Director -
Patricia Randall,
Independent Director -
Andrew Walton,
Independent Director -
Mark Klausner,
Independent Director -
Ronald Andrews,
Independent Director -
Janet Kidd,
General Counsel, Company Secretary -
Herm Rosenman,
-
Richard M. Altieri,
Chief Financial Officer -
Peter Edwardson,
Chief Operations Officer -
Stephen L Spotts,
Director -
Jeff R. Schroeder,
Chief Commercial Officer -
Richard Wenstrup,
Chief Medical Officer -
Stefan C Linn,
Chief Operating Officer -
Elizabeth M Keiley,
VP & General Counsel -
Lifesciences I, L.P.Clarus ...,
-
Leaf Ventures Ii, L.P.New L...,